News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InKine Pharmaceutical Company, Inc. (INKP) Elects John R. Leone To Its Board Of Directors


10/19/2005 5:13:07 PM

BLUE BELL, Pa.--(BUSINESS WIRE)--March 24, 2005--InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced the election of John R. Leone to its Board of Directors. Mr. Leone is currently President and Chief Executive Officer of Cambrex Corporation, a diversified life sciences company. Previously, Mr. Leone was Senior Vice President and Chief Operating Officer at Aventis Pharmaceuticals, Inc., where he was responsible for all U.S. Commercial Operations. Mr. Leone joined the Aventis predecessor company Rhone-Poulenc Rorer (RPR) in 1996 as Vice President and General Manager of the U.S. Prescription Products Division. He later became Senior Vice President and General Manager of RPR, responsible for all U.S. pharmaceutical businesses. Mr. Leone began his pharmaceutical career with Pfizer and American Home Products, holding marketing positions of increasing responsibility in the United States and Europe. He earned a B.S. in engineering from the United States Military Academy at West Point, New York and an M.B.A. with an emphasis in marketing from the University of Colorado.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES